In the stiff model, significantly upregulated genes included C19orf73, FOSB, and FITM1. Studies have demonstrated that FOSB expression is significantly upregulated in chemo-resistant ovarian cancer tissue samples, suggesting that FOSB may serve as a potential therapeutic target for overcoming chemoresistance in ovarian cancer [45]. This evidence concerns the gene FITM1 and ovarian carcinoma.